Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug access
Pharma
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
In light of the suspension being lifted, Ocaliva’s European marketing nod has been revoked “with immediate effect,” Advanz said.
Fraiser Kansteiner
Dec 2, 2024 2:54pm
Eisai ends lorcaserin development in Dravet syndrome
Nov 18, 2024 10:18am
BMS rolls out 10-year drug access plan in lower-income countries
May 22, 2024 10:20am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
GLP-1s still unavailable in lower-income countries: MSF
Mar 28, 2024 8:00am
Viatris launches brand campaign on Nasdaq tower in Times Square
Nov 16, 2023 10:53am
